RecruitingPhase IIIEN originalGlioma (brain cancer)

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This phase III trial compares temporally-modulated pulsed radiation therapy versus standard radiation therapy in treating patients with newly diagnosed, IDH wildtype, MGMT-unmethylated glioblastoma. After completion of surgery, the standard of care for glioblastoma is radiation therapy. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. For older and frail patients, standard treatment also includes the chemotherapy drug temozolomide. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Approximately 70% of glioblastoma patients have MGMT-unmethylated status. MGMT unmethylated tumors are less likely to respond to temozolomide chemotherapy, so there is more reliance on radiation therapy to kill the tumor cells. Recent clinical trials studying new therapies for MGMT-unmethylated glioblastoma have failed to improve outcomes over temozolomide. These recent studies also indicate that 80% of patients experience a decline in memory and thinking function after treatment. TMPRT differs from standard radiation therapy by delivering the same amount of radiation dose in 10-13 "pulses" with 3-minute breaks between pulses. TMPRT with temozolomide may work better than standard radiation therapy with temozolomide in increasing survival, as well as improving memory and thinking function in patients with newly diagnosed, IDH wildtype, MGMT-unmethylated glioblastoma.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek co najmniej 18 lat
  • •Nowo rozpoznany gleјak mózgu bez mutacji IDH
  • •Potwierdzenie zabiegu chirurgicznego z wystarczającą ilością tkanki do badań
  • •Tkanka wysłana do centralnego laboratorium w ciągu 30 dni od operacji
  • •Brak rozsiania nowotworu poza mózg
  • •Ujemny wynik testu ciąży (u osób w wieku rozrodczym)
  • •Biegłość w języku angielskim

✗ Disqualifies

  • •Mutacja IDH potwierdzona w badaniach
  • •Rozsianie nowotwo do opon mózgowo-rdzeniowych lub poza mózg
  • •Biopsia stereotaktyczna bez pełnego wycięcia guza

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 10, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (54)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

Irvine, United States

USC / Norris Comprehensive Cancer Center

Los Angeles, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center

Orange, United States

University of California Davis Comprehensive Cancer Center

Sacramento, United States

Saint Mary's Hospital and Regional Medical Center

Grand Junction, United States

Alton Memorial Hospital

Alton, United States

Decatur Memorial Hospital

Decatur, United States

Northwestern Medicine Cancer Center Kishwaukee

DeKalb, United States

Northwestern Medicine Cancer Center Delnor

Geneva, United States

Cancer Care Center of O'Fallon

O'Fallon, United States

HSHS Saint Elizabeth's Hospital

O'Fallon, United States

Memorial Hospital East

Shiloh, United States

Northwestern Medicine Cancer Center Warrenville

Warrenville, United States

UI Health Care Mission Cancer and Blood - Ankeny Clinic

Ankeny, United States

Saint Anthony Regional Hospital

Carroll, United States

UI Health Care Mission Cancer and Blood - West Des Moines Clinic

Clive, United States

Iowa Methodist Medical Center

Des Moines, United States

UI Health Care Mission Cancer and Blood - Des Moines Clinic

Des Moines, United States

Broadlawns Medical Center

Des Moines, United States

UI Health Care Mission Cancer and Blood - Laurel Clinic

Des Moines, United States

UI Healthcare Mission Cancer and Blood - Pella

Pella, United States

UI Health Care Mission Cancer and Blood - Waukee Clinic

Waukee, United States

University of Kansas Cancer Center

Kansas City, United States

University of Kansas Cancer Center-Overland Park

Overland Park, United States

University of Kansas Hospital-Westwood Cancer Center

Westwood, United States

Maryland Proton Treatment Center

Baltimore, United States

University of Maryland/Greenebaum Cancer Center

Baltimore, United States

UM Upper Chesapeake Medical Center

Bel Air, United States

UM Baltimore Washington Medical Center/Tate Cancer Center

Glen Burnie, United States

Siteman Cancer Center at Saint Peters Hospital

City of Saint Peters, United States

MU Health - University Hospital/Ellis Fischel Cancer Center

Columbia, United States

Siteman Cancer Center at West County Hospital

Creve Coeur, United States

University of Kansas Cancer Center - Briarcliff

Kansas City, United States

University of Kansas Cancer Center - North

Kansas City, United States

University of Kansas Cancer Center - Lee's Summit

Lee's Summit, United States

Washington University School of Medicine

St Louis, United States

Siteman Cancer Center-South County

St Louis, United States

Siteman Cancer Center at Christian Hospital

St Louis, United States

Renown Regional Medical Center

Reno, United States

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, United States

Montefiore Medical Center-Einstein Campus

The Bronx, United States

Montefiore Medical Center-Weiler Hospital

The Bronx, United States

Montefiore Medical Center - Moses Campus

The Bronx, United States

Case Western Reserve University

Cleveland, United States

University of Oklahoma Health Sciences Center

Oklahoma City, United States

ThedaCare Regional Cancer Center

Appleton, United States

University of Wisconsin Carbone Cancer Center - Johnson Creek

Johnson Creek, United States

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center

Madison, United States

University of Wisconsin Carbone Cancer Center - University Hospital

Madison, United States

Froedtert Menomonee Falls Hospital

Menomonee Falls, United States

Medical College of Wisconsin

Milwaukee, United States

Froedtert and MCW Moorland Reserve Health Center

New Berlin, United States

Drexel Town Square Health Center

Oak Creek, United States

Froedtert West Bend Hospital/Kraemer Cancer Center

West Bend, United States

Trial contact

Site Public Contact

Xiao-Tang Kong

PRINCIPAL_INVESTIGATOR

Site Public Contact

Adam Garsa

PRINCIPAL_INVESTIGATOR

Site Public Contact

Ruben C. Fragoso

PRINCIPAL_INVESTIGATOR

Lucas Gilbride

PRINCIPAL_INVESTIGATOR

Site Public Contact

Jiayi Huang

PRINCIPAL_INVESTIGATOR

Bryan A. Faller

PRINCIPAL_INVESTIGATOR

Vinai Gondi

PRINCIPAL_INVESTIGATOR

Site Public Contact

Seema Harichand-Herdt

PRINCIPAL_INVESTIGATOR

Site Public Contact

Site Public Contact

Site Public Contact

Danielle Cunningham

PRINCIPAL_INVESTIGATOR

Mark V. Mishra

PRINCIPAL_INVESTIGATOR

Site Public Contact

Site Public Contact

Site Public Contact

Site Public Contact

Mohamed Abdelhakiem

PRINCIPAL_INVESTIGATOR

Site Public Contact

Suchit H. Patel

PRINCIPAL_INVESTIGATOR

Tony J. Wang

PRINCIPAL_INVESTIGATOR

Justin Tang

PRINCIPAL_INVESTIGATOR

Haley K. Perlow

PRINCIPAL_INVESTIGATOR

Shearwood McClelland

PRINCIPAL_INVESTIGATOR

Joseph A. Bovi

PRINCIPAL_INVESTIGATOR

Brett A. Morris

PRINCIPAL_INVESTIGATOR

Site Public Contact

Michael W. Straza

PRINCIPAL_INVESTIGATOR

Site Public Contact

Site Public Contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/10/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.